| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | AG | AH | AI | AJ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Note: A child is considered to have received SMC if it is either indicated on their SMC card or if their caregiver reports that they received it. | |||||||||||||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||||||||||||
3 | Average across three years | |||||||||||||||||||||||||||||||||||
4 | ||||||||||||||||||||||||||||||||||||
5 | Children in targeted age range who received... | |||||||||||||||||||||||||||||||||||
6 | At least one cycle | At least three cycles | All four cycles | Children 6-7 years old who received at least one dose | ||||||||||||||||||||||||||||||||
7 | 92% | 71% | 55% | 57% | ||||||||||||||||||||||||||||||||
8 | ||||||||||||||||||||||||||||||||||||
9 | - | |||||||||||||||||||||||||||||||||||
10 | 2015 ACCESS-SMC coverage survey results | |||||||||||||||||||||||||||||||||||
11 | ||||||||||||||||||||||||||||||||||||
12 | Country | Received at least 1 cycle | Received at least 3 cycles | Received all 4 cycles | Children 6-7yrs old who received SMC at least once | Source | Target population for ACCESS-SMC project in 2015 | |||||||||||||||||||||||||||||
13 | Burkina Faso | 96% | 84% | 69% | 82% | ACCESS-SMC private coverage information. "Coverage surveys that were later conducted by the LSHTM indicate that around 84% of eligible children received at least 3 cycles of SMC, 69% received all 4 cycles with the remainder each receiving two cycles or less." Pg. 37, ACCESS-SMC multi-country cost analysis, August 2016 | 649,693 | |||||||||||||||||||||||||||||
14 | Chad | 96% | 61% | 23% | 85% | ACCESS-SMC private coverage information. "However, coverage surveys conducted by LSHTM indicate that 82% of children received an SMC card (were reached), and around 60% of eligible children received at least 3 cycles and only 22.7% of the children (3 to 59 months) received the full four cycles, with the remainder each receiving three cycles or less." Pg. 41, ACCESS-SMC multi-country cost analysis, August 2016 | 275,000 | |||||||||||||||||||||||||||||
15 | Guinea | 94% | 72% | 54% | 82% | ACCESS-SMC private coverage information | 210,047 | |||||||||||||||||||||||||||||
16 | Mali | 87% | 56% | 38% | 17% | ACCESS-SMC private coverage information. "Coverage surveys that were later conducted by the LSHTM indicate that the reach of the SMC Programme in Mali has been good, with 86% of children having received an SMC card and at least one cycle of SMC; around 56% of eligible children received at least 3 cycles of SMC, 38% received all 4 cycles. Coverage of the first cycle appears to be highest at around 70%, with coverage at the final cycle in November having the lowest coverage at 50%. This implies that most children here received two cycles or less. This presumably shows that more children were reached than the coverage rate indicates but that many of them received less than the recommended four cycles." Pg. 51, ACCESS-SMC multi-country cost analysis, August 2016 | 809,638 | |||||||||||||||||||||||||||||
17 | Niger | 82% | 63% | 45% | - | ACCESS-SMC private coverage information. "Coverage surveys that were later conducted by the LSHTM indicate that fewer than 50% of the children received the full four cycles, with the remainder each receiving three cycles or less. This presumably shows that more children were reached than the coverage rate indicates but that many of them received less than the recommended four cycles...According to the LSHTM coverage survey, in AguieĢ, 45% of eligible children received four cycles of SMC. In Madaoua, 43% of children received four cycles of SMC. In Zinder, 7% of eligible children received four cycles of SMC. In Maradi, 4% of eligible children received four cycles of SMC." Pg. 56, ACCESS-SMC multi-country cost analysis, August 2016 | 595,901 | |||||||||||||||||||||||||||||
18 | Nigeria | 77% | 61% | 42% | 61% | See Pg. 1, ACCESS-SMC, Nigeria coverage summary report 2015. | 792,133 | |||||||||||||||||||||||||||||
19 | The Gambia | 94% | 84% | 56% | 30% | ACCESS-SMC private coverage information. "Coverage surveys that were later conducted by the LSHTM indicate that the reach of the SMC Programme in the Gambia has been excellent, with around 95% of children having received an SMC card and at least one SMC cycle, over 84% of eligible children received at least 3 cycles of SMC and only 56% of the children received the full four cycles, with the remainder each receiving three cycles or less. This presumably shows that of the children reached, many of them received less than the recommended four cycles." Pg. 66, ACCESS-SMC multi-country cost analysis, August 2016 | 90,925 | |||||||||||||||||||||||||||||
20 | ||||||||||||||||||||||||||||||||||||
21 | Average | 87% | 66% | 46% | 46% | |||||||||||||||||||||||||||||||
22 | ||||||||||||||||||||||||||||||||||||
23 | ||||||||||||||||||||||||||||||||||||
24 | 2016 ACCESS-SMC coverage survey results | |||||||||||||||||||||||||||||||||||
25 | ||||||||||||||||||||||||||||||||||||
26 | Country | Received 0 SMC cycles | Received 1 SMC cycle | Received 2 SMC cycles | Received 3 SMC cycles | Received 4 SMC cycles | Children 6-7yrs old who received SMC at least once | Card available | Slept under a bednet last night | Source | Target population for ACCESS-SMC project in 2016 | Coverage of at least 1 cycle | Coverage of at least 3 cycles | Coverage of all 4 cycles | ||||||||||||||||||||||
27 | Burkina Faso | 1% | 1% | 2% | 5% | 91% | 81% | 67% | 97% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Burkina_Faso.pdf | 1,462,033 | 99% | 96% | 91% | ||||||||||||||||||||||
28 | Chad | 11% | 23% | 28% | 23% | 15% | 57% | 44% | 97% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Chad.pdf | 591,072 | 89% | 39% | 15% | ||||||||||||||||||||||
29 | Guinea | 3% | 3% | 11% | 10% | 73% | 79% | 40% | 84% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Guinea.pdf | 438,124 | 97% | 83% | 73% | ||||||||||||||||||||||
30 | Mali | 9% | 5% | 10% | 20% | 57% | 53% | 26% | 97% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Mali.pdf | 1,479,395 | 91% | 77% | 57% | ||||||||||||||||||||||
31 | Niger | 8% | 6% | 15% | 23% | 49% | 43% | 39% | 94% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Niger.pdf | 1,119,970 | 92% | 71% | 49% | ||||||||||||||||||||||
32 | Nigeria | 10% | 19% | 21% | 20% | 30% | 63% | 41% | 34% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_Nigeria.pdf | 1,783,883 | 90% | 50% | 30% | ||||||||||||||||||||||
33 | The Gambia | 19% | 6% | 10% | 21% | 43% | 15% | 50% | 61% | http://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Coverage_survey_summary_2016_The_Gambia.pdf | 90,925 | 81% | 64% | 43% | ||||||||||||||||||||||
34 | ||||||||||||||||||||||||||||||||||||
35 | Average | 7% | 9% | 13% | 17% | 53% | 61% | 43% | 79% | 93% | 70% | 53% | ||||||||||||||||||||||||
36 | ||||||||||||||||||||||||||||||||||||
37 | ||||||||||||||||||||||||||||||||||||
38 | 2017 coverage survey results: post-round | |||||||||||||||||||||||||||||||||||
39 | ||||||||||||||||||||||||||||||||||||
40 | Country | Received 0 SMC cycles | Received 1 SMC cycle | Received 2 SMC cycles | Received 3 SMC cycles | Received 4 SMC cycles | Source | Target population for Malaria Consortium's SMC program | Coverage of at least 1 cycle | Coverage of at least 3 cycles | Coverage of all 4 cycles | |||||||||||||||||||||||||
41 | Burkina Faso | 1% | 1% | 3% | 6% | 88% | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | 1,737,814 | 99% | 94% | 88% | |||||||||||||||||||||||||
42 | Chad | 5% | 4% | 7% | 18% | 66% | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | 634,406 | 95% | 84% | 66% | |||||||||||||||||||||||||
43 | Nigeria | 11% | 13% | 17% | 15% | 45% | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | 2,107,861 | 89% | 60% | 45% | |||||||||||||||||||||||||
44 | Guinea Bissau | No results | No results | No results | No results | No results | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | 43,784 | No results | No results | No results | |||||||||||||||||||||||||
45 | ||||||||||||||||||||||||||||||||||||
46 | Average (weighted by population targeted in each country) | 6% | 7% | 10% | 12% | 65% | 94% | 76% | 65% | |||||||||||||||||||||||||||
47 | ||||||||||||||||||||||||||||||||||||
48 | [CHECK] 2017 coverage survey results: post-cycle | |||||||||||||||||||||||||||||||||||
49 | ||||||||||||||||||||||||||||||||||||
50 | Country | Cycle 1 | Cycle 2 | Cycle 3 | Cycle 4 | Total person-months of coverage | Source | |||||||||||||||||||||||||||||
51 | Burkina Faso | 95% | 96% | 95% | 95% | 6,598,480 | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | |||||||||||||||||||||||||||||
52 | Chad | 77% | 87% | 94% | 80% | 2,144,292 | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | |||||||||||||||||||||||||||||
53 | Nigeria | 73% | 74% | 61% | 59% | 5,611,125 | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | |||||||||||||||||||||||||||||
54 | Guinea Bissau | No results | No results | No results | No results | 140,281 | https://givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_Update_May_2018_GiveWell_v2.pdf | |||||||||||||||||||||||||||||
55 | ||||||||||||||||||||||||||||||||||||
56 | Average (weighted by population targeted in each country) | 82% | 84% | 78% | 76% | |||||||||||||||||||||||||||||||
57 | Total | 14,494,178 | ||||||||||||||||||||||||||||||||||
58 | Total, after adherence adjustment | 12,684,869 | ||||||||||||||||||||||||||||||||||
59 | Difference with figure used in final calculation | -0.28% | ||||||||||||||||||||||||||||||||||
60 | ||||||||||||||||||||||||||||||||||||
61 | 2017 Coverage survey results: Children 6-7 years old who received at least one dose | |||||||||||||||||||||||||||||||||||
62 | ||||||||||||||||||||||||||||||||||||
63 | Country | Cycle 1 | Cycle 2 | Cycle 3 | Cycle 4 | Average | Source | |||||||||||||||||||||||||||||
64 | Burkina Faso | 47% | 49% | 50% | 49% | 48% | https://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_of_Results_for_Cycle_4_Burkina_Faso_2017.pdf (Table 19) | |||||||||||||||||||||||||||||
65 | Chad | 75% | 73% | 73% | 68% | 72% | https://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_of_Results_for_Cycle_4_Chad_2017.pdf (Table 19) | |||||||||||||||||||||||||||||
66 | Nigeria | 66% | 65% | 58% | 48% | 59% | https://files.givewell.org/files/DWDA%202009/Malaria%20Consortium/Malaria_Consortium_Summary_of_Results_for_Cycle_4_Nigeria_2017.pdf (Table 19) | |||||||||||||||||||||||||||||
67 | Guinea Bissau | No results | No results | No results | No results | |||||||||||||||||||||||||||||||
68 | ||||||||||||||||||||||||||||||||||||
69 | ||||||||||||||||||||||||||||||||||||
70 | ||||||||||||||||||||||||||||||||||||
71 | ||||||||||||||||||||||||||||||||||||
72 | ||||||||||||||||||||||||||||||||||||
73 | ||||||||||||||||||||||||||||||||||||
74 | ||||||||||||||||||||||||||||||||||||
75 | ||||||||||||||||||||||||||||||||||||
76 | ||||||||||||||||||||||||||||||||||||
77 | ||||||||||||||||||||||||||||||||||||
78 | ||||||||||||||||||||||||||||||||||||
79 | ||||||||||||||||||||||||||||||||||||
80 | ||||||||||||||||||||||||||||||||||||
81 | ||||||||||||||||||||||||||||||||||||
82 | ||||||||||||||||||||||||||||||||||||
83 | ||||||||||||||||||||||||||||||||||||
84 | ||||||||||||||||||||||||||||||||||||
85 | ||||||||||||||||||||||||||||||||||||
86 | ||||||||||||||||||||||||||||||||||||
87 | ||||||||||||||||||||||||||||||||||||
88 | ||||||||||||||||||||||||||||||||||||
89 | ||||||||||||||||||||||||||||||||||||
90 | ||||||||||||||||||||||||||||||||||||
91 | ||||||||||||||||||||||||||||||||||||
92 | ||||||||||||||||||||||||||||||||||||
93 | ||||||||||||||||||||||||||||||||||||
94 | ||||||||||||||||||||||||||||||||||||
95 | ||||||||||||||||||||||||||||||||||||
96 | ||||||||||||||||||||||||||||||||||||
97 | ||||||||||||||||||||||||||||||||||||
98 | ||||||||||||||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||||||||||||
100 |